ATOS
Atossa Therapeutics Inc
Price:  
1.22 
USD
Volume:  
1,039,226.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atossa WACC - Weighted Average Cost of Capital

The WACC of Atossa Therapeutics Inc (ATOS) is 8.7%.

The Cost of Equity of Atossa Therapeutics Inc (ATOS) is 13.75%.
The Cost of Debt of Atossa Therapeutics Inc (ATOS) is 5.00%.

Range Selected
Cost of equity 12.10% - 15.40% 13.75%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.9% - 9.5% 8.7%
WACC

Atossa WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.79 1.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 12.10% 15.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.9% 9.5%
Selected WACC 8.7%